Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)

Healthy Clinical Trial

— ATX  

Official title:

Metabolic Adaptations to Chronic and Acute Exercise in Overweight Adults (ATX-Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02701751
• Other study ID #: HUM00102522
• Status: Completed
• Phase: N/A
• Start date: January 2016
• Est. completion date: October 24, 2016

Study information

• Verified date: March 2022
• Source: University of Michigan
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The primary purpose of this study is to examine the effects of chronic exercise training and an acute session of exercise on key risk factors associated with Metabolic Syndrome (e.g., glucose tolerance, blood lipid profile, and blood pressure) and alterations in subcutaneous adipose tissue structure and metabolic function in overweight adults.

Description:

Subjects will be asked to complete the Substrate Metabolism Laboratory General Screening Questionnaire and American Heart Association Health/Fitness Questionnaire to determine if they are eligible to complete the preliminary testing procedures. If eligible, subjects will be asked to visit the Substrate Metabolism Laboratory to participate in the preliminary testing procedures (listed below) before participating in the experimental trial.

PRELIMINARY TESTING PROCEDURES:

• Blood pressure, height and weight measurements

• Body Composition Assessment (~20 min)

• Exercise Fitness Test (~10 min)

• Resting Metabolic Rate (RMR) measurement (~30 min)

• 3 hour Oral Glucose Tolerance Test (OGTT)

EXPERIMENTAL TRIAL:

The evening before the experimental trial, subjects will eat a standardized dinner meal and snack. The meal and snack must be eaten at specific times as indicated by the research staff. After eating the snack, subjects will need to fast (no food or beverages - besides water) overnight.

Participants who exercise regularly will be instructed to exercise exactly 3 days before the experimental trial, and then abstain from their exercise training program until after the study is complete.

In the morning, subjects will return to the Substrate Metabolism Laboratory. The research team will collect a blood sample from the subject's hand or forearm and a small sample of fat tissue in the subject's abdomen with a needle. Next, subjects will exercise on a treadmill at a moderate intensity for about 1 hour. Immediately after exercising the research team will collect a second blood sample. Subjects will remain in the laboratory for 1 hour after exercising, and then the research team will collect another blood and fat tissue sample. Upon completion of the experimental trial, subjects will be provided a snack before leaving the laboratory.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 60
• Est. completion date: October 24, 2016
• Est. primary completion date: October 24, 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• Age: 18-40

• Body Mass Index: 25-35 kg/m2

• Regular exercisers: (=4 days/wk of aerobic exercise; 30-60min/session at moderate and vigorous intensities)

• Non-exercisers: no regularly planned exercise/physical activity

• Women must have regularly occurring menses and must be premenopausal

Exclusion Criteria:

• Blood pressure > 140/90 mm Hg

• Pregnant or lactating

• Evidence/history of cardiovascular or metabolic disease

• Medications known to affect lipid or glucose metabolism

Related Conditions & MeSH terms

• Healthy
• Overweight

Intervention

Other:
• Exercise session
A blood sample and fat biopsy will be obtained before and after the 60 minute moderate exercise session. There is no drug or device intervention in this study.

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PPARg mRNA expression	The study team will quantify the abundance of key adipogenic markers in adipose tissue biopsy samples	change from baseline at 1 hour post exercise
Primary	Cytokine abundance in adipose tissue	The study team will measure cytokine proteins in adipose tissue	change from baseline at 1 hour post exercise
Secondary	Total Cholesterol	Plasma concentrations of total- cholesterol will be measured.	change from baseline at 1 hour post exercise